Pulmatrix Initiates European Pilot Bioequivalence Study of PUR0200 for COPD

Go back to Pulmatrix Initiates European Pilot Bioequivalence Study of PUR0200 for COPD
(NASDAQ: PULM) Delayed: 1.68 --0 (-0%)
Previous Close $1.68    52 Week High $5.56 
Open $1.68    52 Week Low $0.76 
Day High $1.68    P/E N/A 
Day Low $1.68    EPS $0.00 
Volume 10,517